FDA launches investigation into Takeda's Adzynma following reported pediatric death
21st November 2025 Uncategorised 0The FDA has opened an investigation into Takeda’s recombinant protein med Adzynma following the reported death of a pediatric patient who received the drug.
More: FDA launches investigation into Takeda's Adzynma following reported pediatric death
Source: fierce